Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation.

Détails

Ressource 1Demande d'une copie Sous embargo indéterminé.
Etat: Serval
Version: Final published version
Document(s) secondaire(s)
Télécharger: 0_26302407_Postprint.pdf (3587.55 [Ko])
Etat: Serval
Version: de l'auteur
ID Serval
serval:BIB_BD87C4211151
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation.
Périodique
Nature Cell Biology
Auteur(s)
Procopio M.G., Laszlo C., Al Labban D., Kim D.E., Bordignon P., Jo S.H., Goruppi S., Menietti E., Ostano P., Ala U., Provero P., Hoetzenecker W., Neel V., Kilarski W.W., Swartz M.A., Brisken C., Lefort K., Dotto G.P.
ISSN
1476-4679 (Electronic)
ISSN-L
1465-7392
Statut éditorial
Publié
Date de publication
2015
Peer-reviewed
Oui
Volume
17
Numéro
9
Pages
1193-1204
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't Publication Status: ppublish
Résumé
Stromal fibroblast senescence has been linked to ageing-associated cancer risk. However, density and proliferation of cancer-associated fibroblasts (CAFs) are frequently increased. Loss or downmodulation of the Notch effector CSL (also known as RBP-Jκ) in dermal fibroblasts is sufficient for CAF activation and ensuing keratinocyte-derived tumours. We report that CSL silencing induces senescence of primary fibroblasts from dermis, oral mucosa, breast and lung. CSL functions in these cells as a direct repressor of multiple senescence- and CAF-effector genes. It also physically interacts with p53, repressing its activity. CSL is downmodulated in stromal fibroblasts of premalignant skin actinic keratosis lesions and squamous cell carcinomas, whereas p53 expression and function are downmodulated only in the latter, with paracrine FGF signalling as the probable culprit. Concomitant loss of CSL and p53 overcomes fibroblast senescence, enhances expression of CAF effectors and promotes stromal and cancer cell expansion. The findings support a CAF activation-stromal co-evolution model under convergent CSL-p53 control.
Mots-clé
Animals, Carcinoma, Squamous Cell/metabolism, Carcinoma, Squamous Cell/pathology, Cell Aging, Cell Line, Tumor, Down-Regulation, Fibroblasts/physiology, Gene Expression Regulation, Neoplastic, Humans, Immunoglobulin J Recombination Signal Sequence-Binding Protein/genetics, Immunoglobulin J Recombination Signal Sequence-Binding Protein/metabolism, Mice, Receptors, Fibroblast Growth Factor/metabolism, Signal Transduction, Skin Neoplasms/metabolism, Skin Neoplasms/pathology, Tumor Suppressor Protein p53/genetics, Tumor Suppressor Protein p53/metabolism
Pubmed
Web of science
Création de la notice
11/09/2015 8:40
Dernière modification de la notice
03/03/2018 20:58
Données d'usage